Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of aesthetics and medical dermatology. The company was founded by Todd Harris and Frederick C. Beddingfield III on June 27, 2010 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Sienna Biopharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sienna Biopharmaceuticals Inc market cap is $0.00.
What is the 52-week high for Sienna Biopharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sienna Biopharmaceuticals Inc 52 week high is $0.0001 as of September 28, 2025.
What is the 52-week low for Sienna Biopharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sienna Biopharmaceuticals Inc 52 week low is $0.00 as of September 28, 2025.
What is the 50-day moving average of Sienna Biopharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sienna Biopharmaceuticals Inc 50-day moving average is $0.00.